Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2001
11/21/2001EP1155016A1 Process for the production of paroxetine hydrochloride acetone solvate
11/21/2001EP1155015A1 Process for the production of tert-butyl (e)-(6-[2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl](4r,6s)-2,2-dimethyl[1,3]dioxan-4-yl)acetate
11/21/2001EP1155014A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
11/21/2001EP1155010A1 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s
11/21/2001EP1155007A2 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
11/21/2001EP1155006A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical composition containing them
11/21/2001EP1155003A1 Novel guanidine derivatives as inhibitors of cell adhesion
11/21/2001EP1155000A1 2-aminopyridines containing fused ring substituents
11/21/2001EP1154999A1 Nitroxyderivatives having antiinflammatory, analgesic and antithrombotic activity
11/21/2001EP1154998A1 Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy
11/21/2001EP1154997A1 Pharmaceutically active compounds and methods of use thereof
11/21/2001EP1154996A2 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain
11/21/2001EP1154993A1 Thioamide derivatives
11/21/2001EP1154988A1 Mevinolin derivatives
11/21/2001EP1154987A1 Phenylalaninol derivatives
11/21/2001EP1154984A1 Inhibitors for uptake of serotonine, dopamine or norepinephrine
11/21/2001EP1154983A1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
11/21/2001EP1154978A1 Soluble double metal salt of group ia and iia of (-) hydroxycitric acid
11/21/2001EP1154819A2 Treatment regimen for hormone-sensitive cancers
11/21/2001EP1154795A1 Method of treating and diagnosing restless legs syndrome and corresponding means
11/21/2001EP1154794A1 Agent containing an additional local anaesthetic for the treatment of symptoms of parkinson's disease
11/21/2001EP1154786A2 Methods and compositions for altering mucus secretion
11/21/2001EP1154779A2 Treatment regimen for prostate cancer, initiated after androgen ablative therapy has started
11/21/2001EP1154778A2 Pharmaceutical preparation containing dithranol
11/21/2001EP1154777A1 Medicament for treating hypertension
11/21/2001EP1154776A1 Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism
11/21/2001EP1154775A1 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol
11/21/2001EP1154774A1 Quinazoline derivatives as angiogenesis inhibitors
11/21/2001EP1154773A2 Use of antagonists of pg-e for the treatment of neuropathic pain
11/21/2001EP1154772A1 Agent for use in transplantation
11/21/2001EP1154771A1 Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use
11/21/2001EP1154770A2 Premixed formulation of piperacillin sodium and tazobactam sodium injection
11/21/2001EP1154768A1 Gabapentin derivative for preventing and treating visceral pain
11/21/2001EP1154767A1 Substituted stilbene compounds with vascular damaging activity
11/21/2001EP1154766A2 Use of r-aryl propionic acids for producing medicaments to treat diseases in humans and animals, whereby said diseases can be therapeutically influenced by inhibiting the activation of nf-kappa b
11/21/2001EP1154765A1 Effervescent laxatives
11/21/2001EP1154764A1 Epoxide hydrolase complexes and methods therewith
11/21/2001EP1154762A1 Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
11/21/2001EP1154758A1 Controlled release formulation for treating copd
11/21/2001EP1154755A1 Liposome formulations
11/21/2001EP1154749A1 An aqueous non-alcoholic oral rinse containing benzocaine and carbomer
11/21/2001EP1154734A1 Injectable collagen-based system for delivery of cells or therapeutic agents
11/21/2001EP1154692A1 A method of controlling fungal pathogens, and agents useful for same
11/21/2001EP1154691A1 Targeted transscleral controlled release drug delivery to the retina and choroid
11/21/2001EP1154689A1 Method for preparation of pharmaceutical-grade dithiocarbamate
11/21/2001EP1049721B1 Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same
11/21/2001EP1011649B1 Use of endipalene in the treatment of psoriasis
11/21/2001EP0998292B1 Method for inhibiting bone resorption
11/21/2001EP0958277B1 Nitric oxide synthase inhibitors
11/21/2001EP0952974B1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
11/21/2001EP0931079B1 Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase
11/21/2001EP0918774B1 Androgen receptor modulator compounds and methods
11/21/2001EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/21/2001EP0906326B1 Novel aromatic derivatives substituted by a ribose, their method of preparation and application as medicine
11/21/2001EP0904313B1 Absolute molecular weight polymers and methods for their use
11/21/2001EP0900207B1 Pyrazinone thrombin inhibitors
11/21/2001EP0895473B1 Polysaccharide microspheres for the pulmonary delivery of drugs
11/21/2001EP0874643B1 Bioresponsive pharmacologically-active polymers and articles made therefrom
11/21/2001EP0873340B1 Heterocyclic substituted cyclopentane compounds
11/21/2001EP0854727B1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
11/21/2001EP0852469B1 Use of threonine for the treatment of phenylketonuria
11/21/2001EP0842191B1 Cyclosporin derivatives with anti-hiv activity
11/21/2001EP0836645A4 Dry powder formulations of polynucleotide complexes
11/21/2001EP0833667A4 Stabilization of polynucleotide complexes
11/21/2001EP0833638B1 USE OF IMIDAZO 1,5-a]QUINOLONES AS NEUROPROTECTIVE AGENTS
11/21/2001EP0832082B1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
11/21/2001EP0831910B1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
11/21/2001EP0802911B1 Hydrophobic taxane derivatives
11/21/2001EP0784622B1 Naphthyridinone derivatives
11/21/2001EP0772613B1 Process for the production of aminoazobicycloalkanes from oximes
11/21/2001EP0745081B1 indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
11/21/2001EP0742210B1 2-mercaptobenzimidazole derivative and antihyperlipemic or antiarteriosclerotic agent containing the same
11/21/2001EP0719773B1 Imidazolidinone derivative, acid-addition salt thereof, and remedy for senile dementia
11/21/2001EP0708642B1 Taxol derivatives
11/21/2001EP0706398B1 Pharmaceutical composition containing heparin, heparin fragments or their derivatives in combination with glycerol esters
11/21/2001EP0659179B1 Benzo-fused lactams promote release of growth hormone
11/21/2001EP0650480B1 1-arylsulphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines
11/21/2001EP0641328B1 Bridged aza-bicyclic derivatives as substance p antagonists
11/21/2001CN1323346A TPL-2/COT kinase and methods of use
11/21/2001CN1323344A DNA zyme and method for treating restenosis
11/21/2001CN1323316A 丙型肝炎三肽抑制剂 Tripeptide inhibitor of hepatitis C
11/21/2001CN1323314A Inhibitors of caspases
11/21/2001CN1323310A Photocyclized rapamycins
11/21/2001CN1323309A Phenyl yanthine derivatives
11/21/2001CN1323308A New compounds
11/21/2001CN1323307A 1H-imidazopyridine derivatives
11/21/2001CN1323302A N-cimidazolylalkyl) substituted cyclic amines as histamine-H3 agonists or antagonists
11/21/2001CN1323301A Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
11/21/2001CN1323298A New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists
11/21/2001CN1323295A AZA-bicycles which modulate the inhibition of cell adhesion
11/21/2001CN1323294A Cyclic ester or amide derivatives
11/21/2001CN1323291A Diaminopropionic acid derivatives
11/21/2001CN1323289A Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
11/21/2001CN1323215A Inhibition of toxic materials or substances using dendrimers
11/21/2001CN1323214A Anionic or cationic dendrimer antimicrobial or antiparasitic composition
11/21/2001CN1323212A A method of modulating ion channel functional activity
11/21/2001CN1323211A New pharmaceutical uses for NOS inhibitors
11/21/2001CN1323210A Method for treating schizophrenia and means used in said method
11/21/2001CN1323209A Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
11/21/2001CN1323208A Remedies for ocular diseases
1 ... 5963 5964 5965 5966 5967 5968 5969 5970 5971 5972 5973 5974 5975 5976 5977 5978 5979 5980 5981 5982 5983 ... 7860